149 related articles for article (PubMed ID: 2606156)
1. Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes.
Nielsen JA; Mena EE; Williams IH; Nocerini MR; Liston D
Eur J Pharmacol; 1989 Nov; 173(1):53-64. PubMed ID: 2606156
[TBL] [Abstract][Full Text] [Related]
2. The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro.
Hunter AJ; Murray TK; Jones JA; Cross AJ; Green AR
Br J Pharmacol; 1989 Sep; 98(1):79-86. PubMed ID: 2804555
[TBL] [Abstract][Full Text] [Related]
3. Effects of tacrine (THA) on spatial reference memory and cholinergic enzymes in specific rat brain regions.
Jackson JJ; Soliman MR
Life Sci; 1996; 58(1):47-54. PubMed ID: 8628110
[TBL] [Abstract][Full Text] [Related]
4. 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current.
Drukarch B; Kits KS; Van der Meer EG; Lodder JC; Stoof JC
Eur J Pharmacol; 1987 Sep; 141(1):153-7. PubMed ID: 2444444
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.
Smith CP; Bores GM; Petko W; Li M; Selk DE; Rush DK; Camacho F; Winslow JT; Fishkin R; Cunningham DM; Brooks KM; Roehr J; Hartman HB; Davis L; Vargas HM
J Pharmacol Exp Ther; 1997 Feb; 280(2):710-20. PubMed ID: 9023283
[TBL] [Abstract][Full Text] [Related]
6. Multiple effects of tetrahydroaminoacridine on the cholinergic system: biochemical and behavioural aspects.
Adem A; Mohammed AK; Winblad B
J Neural Transm Park Dis Dement Sect; 1990; 2(2):113-28. PubMed ID: 2222779
[TBL] [Abstract][Full Text] [Related]
7. Interaction of 9-amino-1,2,3,4-tetrahydroaminoacridine (THA) with human cortical nicotinic and muscarinic receptor binding in vitro.
Perry EK; Smith CJ; Court JA; Bonham JR; Rodway M; Atack JR
Neurosci Lett; 1988 Aug; 91(2):211-6. PubMed ID: 3185960
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of tetrahydroaminoacridine-evoked release of endogenous 5-hydroxytryptamine and dopamine from rat brain tissue prisms.
Robinson TN; De Souza RJ; Cross AJ; Green AR
Br J Pharmacol; 1989 Dec; 98(4):1127-36. PubMed ID: 2611486
[TBL] [Abstract][Full Text] [Related]
9. The effect of tacrine (THA) on cycloheximide- and basal forebrain lesion-induced memory deficit in rats.
Nabeshima T; Maruyama E; Katoh A; Kameyama T
Jpn J Pharmacol; 1991 Nov; 57(3):311-9. PubMed ID: 1813659
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological significance of acetylcholinesterase inhibition by tetrahydroaminoacridine.
Marquis JK
Biochem Pharmacol; 1990 Sep; 40(5):1071-6. PubMed ID: 2390104
[TBL] [Abstract][Full Text] [Related]
11. 9-Amino-1,2,3,4-tetrahydroacridine (THA) blocks agonist-induced potassium conductance in rat hippocampal neurones.
Halliwell JV; Grove EA
Eur J Pharmacol; 1989 Apr; 163(2-3):369-72. PubMed ID: 2721578
[TBL] [Abstract][Full Text] [Related]
12. Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease.
Drukarch B; Leysen JE; Stoof JC
Life Sci; 1988; 42(9):1011-7. PubMed ID: 2893967
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of anti-amnesic effect of extracts of selected Ocimum species using in-vitro and in-vivo models.
Singh V; Kahol A; Singh IP; Saraf I; Shri R
J Ethnopharmacol; 2016 Dec; 193():490-499. PubMed ID: 27725240
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of rat brain histamine-N-methyltransferase by 9-amino-1,2,3,4-tetrahydroacridine (THA).
Cumming P; Reiner PB; Vincent SR
Biochem Pharmacol; 1990 Sep; 40(6):1345-50. PubMed ID: 2403387
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic receptor function and acetylcholinesterase activity after chronic administration of tacrine to mice at therapeutic drug concentrations.
Kiefer-Day JS; el-Fakahany EE
Pharmacology; 1992; 44(2):71-80. PubMed ID: 1315062
[TBL] [Abstract][Full Text] [Related]
16. Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats.
Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
Eur J Pharmacol; 1999 Sep; 380(2-3):101-7. PubMed ID: 10513568
[TBL] [Abstract][Full Text] [Related]
17. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
Flynn DD; Mash DC
J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841
[TBL] [Abstract][Full Text] [Related]
18. The dual-acting AChE inhibitor and H3 receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats.
Sadek B; Khan N; Darras FH; Pockes S; Decker M
Physiol Behav; 2016 Oct; 165():383-91. PubMed ID: 27568232
[TBL] [Abstract][Full Text] [Related]
19. In vitro inactivation of rat brain acetylcholinesterase by DSP-4 and its derivatives OS-21 and OS-23 and protective activity of tacrine (9-amino-1,2,3,4-tetrahydroacridine).
Patockal J; Jun D; Kucal K
Acta Medica (Hradec Kralove); 2005; 48(3-4):145-8. PubMed ID: 16640027
[TBL] [Abstract][Full Text] [Related]
20. Application of a brain-targeting chemical delivery system to 9-amino-1,2,3,4-tetrahydroacridine.
Pop E; Prókai-Tátrai K; Scott JD; Brewster ME; Bodor N
Pharm Res; 1990 Jun; 7(6):658-64. PubMed ID: 2367335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
